Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

NCT00180024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2005-09-16

No results posted yet for this study

Summary

The hypothesis is tested that stimulation with angiotensin II after blockade of the AT1-receptor results in venodilation in human healthy subjects in vivo.

Conditions

  • Healthy Subjects

Interventions

DRUG

irbesartan (drug)

Sponsors & Collaborators

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Wilhelm Kirch, MD · Institute of Clinical Pharmacology

Study Design

Allocation
NON_RANDOMIZED
Purpose
ECT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-01-31
Completion
2005-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180024 on ClinicalTrials.gov